Literature DB >> 32586307

Age-dependent changes in anti-Müllerian hormone levels in Lebanese females: correlation with basal FSH and LH levels and LH/FSH ratio: a cross-sectional study.

Eddie Racoubian1, Gulzhanat Aimagambetova2, Ramzi R Finan3, Wassim Y Almawi4,5,6.   

Abstract

BACKGROUND: To investigate the age-dependent changes in circulating anti-Müllerian hormone (AMH) levels in healthy Arabic-speaking Lebanese women, and to correlate changes in serum AMH levels with serum FSH and LH values, and LH/FSH ratio.
METHODS: Cross-sectional study, involving 1190 healthy females, age 17-54 years, with regular menses and both ovaries. Serum AMH levels (ng/ml) were measured by ELISA.
RESULTS: There was an inverse proportion of AMH and subject's age, which declined from median 6.71 (2.91) ng/ml in young subjects, to 0.68 (0.45) ng/ml in subjects older than 50 years. Average yearly decrease in median AMH levels was 0.27 ng/ml/year through age 35, but then diminished to 0.12 ng/ml/year afterwards. Receiver operating characteristic curve analysis demonstrated high sensitivity and specificity of age as determinant of AMH levels. In contrast to AMH, FSH levels increased progressively from 5.89 (0.11-62.10) ng/ml in young subjects, to 38.43 (3.99-88.30) ng/ml in subjects older than 50 years. On the other hand, age-dependent changes in LH/FSH ratio paralleled those of AMH. Linear regression modeling testing the independent effect of AMH on FSH and LH, adjusted for age, showed that AMH was significant predictor of FSH and LH/FSH ratio, but not LH. This did not contribute significantly to baseline LH and FSH prediction.
CONCLUSIONS: Circulating AMH levels are inversely related to age as also shown elsewhere, and are predictors of LH/FSH ratio and FSH but not LH levels in eumenorrheic females.

Entities:  

Keywords:  Anti-Müllerian hormone; Follicle-stimulating hormone; Luteinizing hormone; Menopause

Year:  2020        PMID: 32586307     DOI: 10.1186/s12905-020-00998-4

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  3 in total

1.  Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk.

Authors:  Rui Gao; Xin Liao; Wanrong Huang; Rujun Zeng; Lang Qin; Peng Bai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

2.  Association between baseline LH/FSH and live-birth rate after fresh-embryo transfer in polycystic ovary syndrome women.

Authors:  Nian-Jun Su; Cui-Yu Huang; Jie Liu; De-Ying Kang; Song-Lu Wang; Liu-Jun Liao; Jin-di Yang; Xi-Qian Zhang; Feng-Hua Liu
Journal:  Sci Rep       Date:  2021-10-14       Impact factor: 4.379

3.  Anti-Müllerian hormone independently affect mtDNA copy number in human granulosa cells.

Authors:  Anom Bowolaksono; Ayu Mulia Sundari; Muhammad Fauzi; Mila Maidarti; Budi Wiweko; Kresna Mutia; Pritta Ameilia Iffanolida; Ririn Rahmala Febri; Astari Dwiranti; Hiroaki Funahashi
Journal:  J Ovarian Res       Date:  2022-10-13       Impact factor: 5.506

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.